The MedMen of Nevada 2 LLC Acquires Shares Redeemable for Class B Subordinate Voting Shares of MedMen Enterprises Inc.

VANCOUVER, May 29, 2018 /CNW/ - On May 28, 2018, MedMen Enterprises Inc. (formerly Ladera Ventures Corp.) (the "Issuer"), located at 10115 Jefferson Blvd, Culver City, CA 90232, and MM Enterprises USA, LLC (the "LLC") completed their previously announced business combination (the "Business Combination"), creating a U.S. based medical and adult use cannabis company listed on the Canadian Securities Exchange.

The MedMen of Nevada 2 LLC (the "Acquiror"), located at 10115 Jefferson Blvd, Culver City, CA 90232, announced today that in connection with the Business Combination it acquired 16,574,460 Class B Common Shares ("Class B Shares") of MM Can USA, Inc. ("PC Corp"), a subsidiary of the Issuer, pursuant to a contribution by the Acquiror of the same number of units of the LLC in exchange for such Class B Shares (the "Acquired Shares").

The Acquired Shares represent ownership and control of approximately 37% of the Issuer's issued and outstanding Class B Subordinate Voting Shares (the "Subordinate Voting Shares") after the Business Combination on a partially-diluted basis and approximately 4% on a fully-diluted basis. The Acquiror does not currently own or control any Subordinate Voting Shares or, other than the Acquired Shares, any other securities of the Issuer, PC Corp or the LLC.

Pursuant to the articles of incorporation of PC Corp and the Support Agreement dated as of May 28, 2018 between the Issuer, PC Corp and the LLC, and subject to the terms and conditions thereof, the Acquired Shares may be redeemed from time to time by the Acquiror for cash or an equivalent number of Subordinate Voting Shares, with the form of such redemption consideration being at the option of PC Corp.

This press release is issued pursuant to National Instrument 62-103 ? The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, which requires a report to be filed on SEDAR (www.sedar.com) containing additional information with respect to the foregoing matters. A copy of this report may be obtained by contacting Investor Relations, MedMen Enterprises, at [email protected].

SOURCE MedMen Enterprises Inc.